HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Bassem N. Mora Carlos H.R. Boasquevisque G. Alexander Patterson Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mora, B. N. Articles by Patterson, G. A. Search for Related Content PubMed PubMed Citation Articles by Mora, B. N. Articles by Patterson, G. A.

Ann Thorac Surg 2000;69:210-215
© 2000 The Society of Thoracic Surgeons

---

Original Articles

Exhaled nitric oxide correlates with experimental lung transplant rejection

^a Division of Cardiothoracic Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri, USA
^b Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri, USA

Address reprint requests to Dr Patterson, Division of Cardiothoracic Surgery, Washington University School of Medicine, One Barnes-Jewish Hospital Plaza, Suite 3108 Queeny Tower, St. Louis, MO 63110

Presented at the Forty-fifth Annual Meeting of the Southern Thoracic Surgical Association, Orlando, FL, Nov 12–14, 1998.

Background. Increased nitric oxide production accompanies acute lung allograft rejection. Transforming growth factor-ß1 is an immunosuppressive cytokine capable of ameliorating acute rejection. The purpose of this study was to determine whether exhaled nitric oxide (eNO) concentrations correlated with the degree of acute rejection.

Methods. A model of acute lung transplant rejection in the rat was developed, and concentrations of eNO were measured at the time of animal sacrifice. In group 1 (partial immunosuppression), donor lungs were pretreated with transforming growth factor-ß1 before implantation. In group 2 (fulminant acute rejection), no immunosuppression was used. In group 3 (full immunosuppression), recipients received cyclosporine. Group 4 were normal rats.

Results. When measured from both lungs, eNO concentrations were 4.97 ± 0.68 versus 6.73 ± 2.90 ppb for groups 1 and 2, respectively (p = 0.58). When measured selectively from transplanted left lungs, eNO concentrations were 8.61 ± 0.97 versus 42.14 ± 7.27 ppb, respectively (p < 0.001). In groups 3 and 4, eNO concentrations were 1.02 ± 0.21 and 1.51 ± 0.74 ppb, respectively.

Conclusions. Exhaled nitric oxide is elevated in fulminant acute rejection, is reduced after partial immunosuppression using transforming growth factor-ß1 gene therapy, and is in the normal range in cyclosporine-treated animals. The measurement of eNO correlates with the degree of acute lung allograft rejection and may serve as a noninvasive measure of acute lung transplant rejection in the clinical setting.

This article has been cited by other articles:

				C. Alexiou, A. T.M. Tang, S. V. Sheppard, M. P. Haw, R. Gibbs, and D. C. Smith A Prospective Randomized Study to Evaluate the Effect of Leukodepletion on the Rate of Alveolar Production of Exhaled Nitric Oxide During Cardiopulmonary Bypass Ann. Thorac. Surg., December 1, 2004; 78(6): 2139 - 2145. [Abstract] [Full Text] [PDF]

				C. E. Reed General thoracic surgery and the Southern Thoracic Surgical Association: the second 25 years Ann. Thorac. Surg., November 1, 2003; 76(90050): S14 - 16. [Full Text] [PDF]

				H. Itano, B. N. Mora, W. Zhang, J. H. Ritter, T. J. McCarthy, N. S. Yew, T. Mohanakumar, and G. A. Patterson Lipid-mediated ex vivo gene transfer of viral interleukin 10 in rat lung allotransplantation J. Thorac. Cardiovasc. Surg., July 1, 2001; 122(1): 29 - 38. [Abstract] [Full Text] [PDF]